Ticker · CUSIP 88322Q108

TGTX

TG THERAPEUTICS INC
···Share
Holders (tracked)
13
Combined shares
5,726,722
Combined value
$152.67M
Last close
$34.30
Quarter
2025Q4
Tracked holders · last 8 quarters
+1 vs previous quarter over the last 8.
13142024Q12025Q4
Price is +28.7% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

20 events
  1. +68,197 shares · 2025Q4
    13F
  2. +18,334 shares · 2025Q4
    13F
  3. +170,578 shares · 2025Q4
    13F
  4. +385,023 shares · 2025Q4
    13F
  5. +468,322 shares · 2025Q4
    13F
  6. −134,474 shares · 2025Q4
    13F
  7. −352,526 shares · 2025Q4
    13F
  8. +903 shares · 2025Q4
    13F
  9. +96,609 shares · 2025Q4
    13F
  10. +127,706 shares · 2025Q4
    13F
  11. +34,462 shares · 2025Q3
    13F
  12. −324,846 shares · 2025Q3
    13F
  13. −351,678 shares · 2025Q3
    13F
  14. +276,163 shares · 2025Q3
    13F
  15. +113,886 shares · 2025Q3
    13F
  16. −589,073 shares · 2025Q3
    13F
  17. −1,168,995 shares · 2025Q3
    13F
  18. −89,820 shares · 2025Q3
    13F
  19. +342,149 shares · 2025Q3
    13F
  20. −159,836 shares · 2024Q3
    13F

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of TGTX…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2016Q3$0.41+8332.5%$20.8M
Two Sigma Investments2017Q1$27.10+26.6%$36.4M
Paul Tudor Jones (Tudor Investment)2016Q2$28.88+18.8%$3.3M
AQR Capital Management2017Q2$29.09+17.9%$4.7M
D.E. Shaw & Co.2017Q1$30.25+13.4%$2.3M
D.E. Shaw & Co.2017Q1$30.25+13.4%$2.3M
Ken Griffin (Citadel Advisors)2016Q2$31.61+8.5%$7.7M
Ken Griffin (Citadel Advisors)2016Q2$31.61+8.5%$7.7M
Ken Griffin (Citadel Advisors)2016Q2$31.61+8.5%$7.7M
Izzy Englander (Millennium Mgmt)2016Q2$32.47+5.6%$23.2M
Steve Cohen (Point72)2018Q1$33.22+3.3%$7.9M
Ray Dalio (Bridgewater Associates)2025Q3$34.41-0.3%$16.1M
Wellington Management2018Q1$38.27-10.4%$2.1M

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions1
Trimmed2
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q1
15
$9.86B
2022Q2
14
$4.67B
2022Q3
15
$6.9M
2022Q4
14
$274.0M
2023Q1
13
$259.1M
2023Q2
15
$496.5M
2023Q3
14
$144.9M
2023Q4
13
$286.3M
2024Q1
14
$321.9M
2024Q2
15
$328.0M
2024Q3
11
$66.9M
2024Q4
9
$80.8M
2025Q1
14
$162.8M
2025Q2
14
$197.4M
2025Q3
12
$145.2M
2025Q4
13
$152.7M

Who owns TGTX

13 super-investors · 2025Q4
Tracked stake
5.73M
shares
Combined value
$153M
% of shares outstanding
shares-out unknown
Quarter action mix
New1Added10Trim2
#ManagerSharesValue
1Two Sigma Investments1.06M$32M
2Ken Griffin
Citadel Advisors
1.01M$30M
3D.E. Shaw & Co.700.3K$21M
4Izzy Englander
Millennium Mgmt
675.9K$20M
5Ray Dalio
Bridgewater Associates
469.9K$14M
6Ken Griffin
Citadel Advisors
385.8K$12M
7Steve Cohen
Point72
231.4K$7M
8Ken Griffin
Citadel Advisors
223.8K$7M
9AQR Capital Management136.0K$4M
10Paul Tudor Jones
Tudor Investment
96.6K$3M
11D.E. Shaw & Co.68.1K$2M
12Wellington Management61.5K$2M
13T. Rowe Price605.9K$18K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live TGTX chart.
<iframe src="https://openstocks.me/embed/stock/TGTX" width="100%" height="480" frameborder="0" loading="lazy" title="TGTX chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>